Hemato Oncology Testing Market 2027 By Product And Service, Cancer Type, Technology, End User and Geography | The Insight Partners

Hemato Oncology Testing Market to 2027 - Global Analysis and Forecasts by Product And Service (Services, Assay Kits); Cancer Type (Leukemia, Lymphoma); Technology (PCR, IHS, NGS, Cytogenetics, Other Technologies); End User (Clinical Laboratories, Hospitals, Academic And Research Institutes, Other End Users) and Geography

Report Code: TIPRE00006530 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
MARKET INTRODUCTION

The diagnosis, medication, and prevention of blood diseases is called hematology, and cancer is called oncology. Hematology-oncology includes diseases such as hemophilia, iron deficiency anemia, leukemias, and lymphomas, sickle cell disease, the thalassemias, as well as cancers of other organs.

MARKET DYNAMICS

Growth of the market is mainly propelled by the rising awareness about personalized medicines, rising global prevalence of hematologic cancer, and expanding collaborations for developing new assays. However, uncertain reimbursement scenario in different regions is expected to hamper the growth of this market during the forecast period.

MARKET SCOPE

The "Global Hemato Oncology Testing Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of Hemato Oncology Testing Market with detailed market segmentation by product & services, cancer type, technology, end user and geography. The global Hemato Oncology Testing Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Hemato Oncology Testing Market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global Hemato Oncology Testing Market is segmented on the basis of product & services, cancer type, technology, and end user. Based on product & services the market is segmented into services and assay kits. On the basis of the cancer type the market is segmented as leukemia and lymphoma. Market based on end user is segmented into hospitals, clinics and clinical laboratories

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Hemato Oncology Testing Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Hemato Oncology Testing Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Hemato Oncology Testing market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Hemato Oncology Testing Market in these regions.


MARKET PLAYERS

The reports cover key developments in the Hemato Oncology Testing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Hemato Oncology Testing Market are anticipated to lucrative growth opportunities in the future with the rising demand for Hemato Oncology Testing market in the global market. Below mentioned is the list of few companies engaged in the Hemato Oncology Testing market.

The report also includes the profiles of key Hemato Oncology Testing Market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- F. Hoffman-La Roche Ltd.
- Abbott Laboratories
- Qiagen N.V.
- Thermo Fisher Scientific, Inc.
- Illumina, Inc.
- Bio-Rad Laboratories, Inc.
- Molecularmd (Subsidiary of Icon PLC)
- Archerdx, Inc.
- Arup Laboratories Inc.
- Asuragen, Inc. (Suzhou)

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Hemato Oncology Testing Market - By Product Ans Service
1.3.2 Hemato Oncology Testing Market - By Cancer Type
1.3.3 Hemato Oncology Testing Market - By Technology
1.3.4 Hemato Oncology Testing Market - By End User
1.3.5 Hemato Oncology Testing Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. HEMATO ONCOLOGY TESTING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. HEMATO ONCOLOGY TESTING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. HEMATO ONCOLOGY TESTING MARKET - GLOBAL MARKET ANALYSIS
6.1. HEMATO ONCOLOGY TESTING - GLOBAL MARKET OVERVIEW
6.2. HEMATO ONCOLOGY TESTING - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. HEMATO ONCOLOGY TESTING MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT ANS SERVICE
7.1. OVERVIEW
7.2. PRODUCT ANS SERVICE MARKET FORECASTS AND ANALYSIS
7.3. SERVICES
7.3.1. Overview
7.3.2. Services Market Forecast and Analysis
7.4. ASSAY KITS
7.4.1. Overview
7.4.2. Assay Kits Market Forecast and Analysis
8. HEMATO ONCOLOGY TESTING MARKET - REVENUE AND FORECASTS TO 2027 - CANCER TYPE
8.1. OVERVIEW
8.2. CANCER TYPE MARKET FORECASTS AND ANALYSIS
8.3. LEUKEMIA
8.3.1. Overview
8.3.2. Leukemia Market Forecast and Analysis
8.3.3. Acute Myeloid Leukemia Market
8.3.3.1. Overview
8.3.3.2. Acute Myeloid Leukemia Market Forecast and Analysis
8.3.4. Acute Lymphocytic Leukemia Market
8.3.4.1. Overview
8.3.4.2. Acute Lymphocytic Leukemia Market Forecast and Analysis
8.3.5. Other Leukemias Market
8.3.5.1. Overview
8.3.5.2. Other Leukemias Market Forecast and Analysis
8.4. LYMPHOMA
8.4.1. Overview
8.4.2. Lymphoma Market Forecast and Analysis
8.4.3. Non-Hodgkin Lymphoma Market
8.4.3.1. Overview
8.4.3.2. Non-Hodgkin Lymphoma Market Forecast and Analysis
8.4.4. Hodgkin Lymphoma Market
8.4.4.1. Overview
8.4.4.2. Hodgkin Lymphoma Market Forecast and Analysis
8.4.5. Other Market
8.4.5.1. Overview
8.4.5.2. Other Market Forecast and Analysis
9. HEMATO ONCOLOGY TESTING MARKET - REVENUE AND FORECASTS TO 2027 - TECHNOLOGY
9.1. OVERVIEW
9.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
9.3. PCR
9.3.1. Overview
9.3.2. PCR Market Forecast and Analysis
9.4. IHS
9.4.1. Overview
9.4.2. IHS Market Forecast and Analysis
9.5. NGS
9.5.1. Overview
9.5.2. NGS Market Forecast and Analysis
9.6. CYTOGENETICS
9.6.1. Overview
9.6.2. Cytogenetics Market Forecast and Analysis
9.7. OTHER TECHNOLOGIES
9.7.1. Overview
9.7.2. Other Technologies Market Forecast and Analysis
10. HEMATO ONCOLOGY TESTING MARKET - REVENUE AND FORECASTS TO 2027 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. CLINICAL LABORATORIES
10.3.1. Overview
10.3.2. Clinical Laboratories Market Forecast and Analysis
10.4. HOSPITALS
10.4.1. Overview
10.4.2. Hospitals Market Forecast and Analysis
10.5. ACADEMIC AND RESEARCH INSTITUTES
10.5.1. Overview
10.5.2. Academic And Research Institutes Market Forecast and Analysis
10.6. OTHER END USERS
10.6.1. Overview
10.6.2. Other End Users Market Forecast and Analysis
11. HEMATO ONCOLOGY TESTING MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Hemato Oncology Testing Market Overview
11.1.2 North America Hemato Oncology Testing Market Forecasts and Analysis
11.1.3 North America Hemato Oncology Testing Market Forecasts and Analysis - By Product Ans Service
11.1.4 North America Hemato Oncology Testing Market Forecasts and Analysis - By Cancer Type
11.1.5 North America Hemato Oncology Testing Market Forecasts and Analysis - By Technology
11.1.6 North America Hemato Oncology Testing Market Forecasts and Analysis - By End User
11.1.7 North America Hemato Oncology Testing Market Forecasts and Analysis - By Countries
11.1.7.1 United States Hemato Oncology Testing Market
11.1.7.1.1 United States Hemato Oncology Testing Market by Product Ans Service
11.1.7.1.2 United States Hemato Oncology Testing Market by Cancer Type
11.1.7.1.3 United States Hemato Oncology Testing Market by Technology
11.1.7.1.4 United States Hemato Oncology Testing Market by End User
11.1.7.2 Canada Hemato Oncology Testing Market
11.1.7.2.1 Canada Hemato Oncology Testing Market by Product Ans Service
11.1.7.2.2 Canada Hemato Oncology Testing Market by Cancer Type
11.1.7.2.3 Canada Hemato Oncology Testing Market by Technology
11.1.7.2.4 Canada Hemato Oncology Testing Market by End User
11.1.7.3 Mexico Hemato Oncology Testing Market
11.1.7.3.1 Mexico Hemato Oncology Testing Market by Product Ans Service
11.1.7.3.2 Mexico Hemato Oncology Testing Market by Cancer Type
11.1.7.3.3 Mexico Hemato Oncology Testing Market by Technology
11.1.7.3.4 Mexico Hemato Oncology Testing Market by End User
11.2. EUROPE
11.2.1 Europe Hemato Oncology Testing Market Overview
11.2.2 Europe Hemato Oncology Testing Market Forecasts and Analysis
11.2.3 Europe Hemato Oncology Testing Market Forecasts and Analysis - By Product Ans Service
11.2.4 Europe Hemato Oncology Testing Market Forecasts and Analysis - By Cancer Type
11.2.5 Europe Hemato Oncology Testing Market Forecasts and Analysis - By Technology
11.2.6 Europe Hemato Oncology Testing Market Forecasts and Analysis - By End User
11.2.7 Europe Hemato Oncology Testing Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Hemato Oncology Testing Market
11.2.7.1.1 Germany Hemato Oncology Testing Market by Product Ans Service
11.2.7.1.2 Germany Hemato Oncology Testing Market by Cancer Type
11.2.7.1.3 Germany Hemato Oncology Testing Market by Technology
11.2.7.1.4 Germany Hemato Oncology Testing Market by End User
11.2.7.2 France Hemato Oncology Testing Market
11.2.7.2.1 France Hemato Oncology Testing Market by Product Ans Service
11.2.7.2.2 France Hemato Oncology Testing Market by Cancer Type
11.2.7.2.3 France Hemato Oncology Testing Market by Technology
11.2.7.2.4 France Hemato Oncology Testing Market by End User
11.2.7.3 Italy Hemato Oncology Testing Market
11.2.7.3.1 Italy Hemato Oncology Testing Market by Product Ans Service
11.2.7.3.2 Italy Hemato Oncology Testing Market by Cancer Type
11.2.7.3.3 Italy Hemato Oncology Testing Market by Technology
11.2.7.3.4 Italy Hemato Oncology Testing Market by End User
11.2.7.4 Spain Hemato Oncology Testing Market
11.2.7.4.1 Spain Hemato Oncology Testing Market by Product Ans Service
11.2.7.4.2 Spain Hemato Oncology Testing Market by Cancer Type
11.2.7.4.3 Spain Hemato Oncology Testing Market by Technology
11.2.7.4.4 Spain Hemato Oncology Testing Market by End User
11.2.7.5 United Kingdom Hemato Oncology Testing Market
11.2.7.5.1 United Kingdom Hemato Oncology Testing Market by Product Ans Service
11.2.7.5.2 United Kingdom Hemato Oncology Testing Market by Cancer Type
11.2.7.5.3 United Kingdom Hemato Oncology Testing Market by Technology
11.2.7.5.4 United Kingdom Hemato Oncology Testing Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Hemato Oncology Testing Market Overview
11.3.2 Asia-Pacific Hemato Oncology Testing Market Forecasts and Analysis
11.3.3 Asia-Pacific Hemato Oncology Testing Market Forecasts and Analysis - By Product Ans Service
11.3.4 Asia-Pacific Hemato Oncology Testing Market Forecasts and Analysis - By Cancer Type
11.3.5 Asia-Pacific Hemato Oncology Testing Market Forecasts and Analysis - By Technology
11.3.6 Asia-Pacific Hemato Oncology Testing Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific Hemato Oncology Testing Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Hemato Oncology Testing Market
11.3.7.1.1 Australia Hemato Oncology Testing Market by Product Ans Service
11.3.7.1.2 Australia Hemato Oncology Testing Market by Cancer Type
11.3.7.1.3 Australia Hemato Oncology Testing Market by Technology
11.3.7.1.4 Australia Hemato Oncology Testing Market by End User
11.3.7.2 China Hemato Oncology Testing Market
11.3.7.2.1 China Hemato Oncology Testing Market by Product Ans Service
11.3.7.2.2 China Hemato Oncology Testing Market by Cancer Type
11.3.7.2.3 China Hemato Oncology Testing Market by Technology
11.3.7.2.4 China Hemato Oncology Testing Market by End User
11.3.7.3 India Hemato Oncology Testing Market
11.3.7.3.1 India Hemato Oncology Testing Market by Product Ans Service
11.3.7.3.2 India Hemato Oncology Testing Market by Cancer Type
11.3.7.3.3 India Hemato Oncology Testing Market by Technology
11.3.7.3.4 India Hemato Oncology Testing Market by End User
11.3.7.4 Japan Hemato Oncology Testing Market
11.3.7.4.1 Japan Hemato Oncology Testing Market by Product Ans Service
11.3.7.4.2 Japan Hemato Oncology Testing Market by Cancer Type
11.3.7.4.3 Japan Hemato Oncology Testing Market by Technology
11.3.7.4.4 Japan Hemato Oncology Testing Market by End User
11.3.7.5 South Korea Hemato Oncology Testing Market
11.3.7.5.1 South Korea Hemato Oncology Testing Market by Product Ans Service
11.3.7.5.2 South Korea Hemato Oncology Testing Market by Cancer Type
11.3.7.5.3 South Korea Hemato Oncology Testing Market by Technology
11.3.7.5.4 South Korea Hemato Oncology Testing Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Hemato Oncology Testing Market Overview
11.4.2 Middle East and Africa Hemato Oncology Testing Market Forecasts and Analysis
11.4.3 Middle East and Africa Hemato Oncology Testing Market Forecasts and Analysis - By Product Ans Service
11.4.4 Middle East and Africa Hemato Oncology Testing Market Forecasts and Analysis - By Cancer Type
11.4.5 Middle East and Africa Hemato Oncology Testing Market Forecasts and Analysis - By Technology
11.4.6 Middle East and Africa Hemato Oncology Testing Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa Hemato Oncology Testing Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Hemato Oncology Testing Market
11.4.7.1.1 South Africa Hemato Oncology Testing Market by Product Ans Service
11.4.7.1.2 South Africa Hemato Oncology Testing Market by Cancer Type
11.4.7.1.3 South Africa Hemato Oncology Testing Market by Technology
11.4.7.1.4 South Africa Hemato Oncology Testing Market by End User
11.4.7.2 Saudi Arabia Hemato Oncology Testing Market
11.4.7.2.1 Saudi Arabia Hemato Oncology Testing Market by Product Ans Service
11.4.7.2.2 Saudi Arabia Hemato Oncology Testing Market by Cancer Type
11.4.7.2.3 Saudi Arabia Hemato Oncology Testing Market by Technology
11.4.7.2.4 Saudi Arabia Hemato Oncology Testing Market by End User
11.4.7.3 U.A.E Hemato Oncology Testing Market
11.4.7.3.1 U.A.E Hemato Oncology Testing Market by Product Ans Service
11.4.7.3.2 U.A.E Hemato Oncology Testing Market by Cancer Type
11.4.7.3.3 U.A.E Hemato Oncology Testing Market by Technology
11.4.7.3.4 U.A.E Hemato Oncology Testing Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Hemato Oncology Testing Market Overview
11.5.2 South and Central America Hemato Oncology Testing Market Forecasts and Analysis
11.5.3 South and Central America Hemato Oncology Testing Market Forecasts and Analysis - By Product Ans Service
11.5.4 South and Central America Hemato Oncology Testing Market Forecasts and Analysis - By Cancer Type
11.5.5 South and Central America Hemato Oncology Testing Market Forecasts and Analysis - By Technology
11.5.6 South and Central America Hemato Oncology Testing Market Forecasts and Analysis - By End User
11.5.7 South and Central America Hemato Oncology Testing Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Hemato Oncology Testing Market
11.5.7.1.1 Brazil Hemato Oncology Testing Market by Product Ans Service
11.5.7.1.2 Brazil Hemato Oncology Testing Market by Cancer Type
11.5.7.1.3 Brazil Hemato Oncology Testing Market by Technology
11.5.7.1.4 Brazil Hemato Oncology Testing Market by End User
11.5.7.2 Argentina Hemato Oncology Testing Market
11.5.7.2.1 Argentina Hemato Oncology Testing Market by Product Ans Service
11.5.7.2.2 Argentina Hemato Oncology Testing Market by Cancer Type
11.5.7.2.3 Argentina Hemato Oncology Testing Market by Technology
11.5.7.2.4 Argentina Hemato Oncology Testing Market by End User
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. HEMATO ONCOLOGY TESTING MARKET, KEY COMPANY PROFILES
13.1. F. HOFFMAN-LA ROCHE LTD.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. ABBOTT LABORATORIES
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. QIAGEN N.V.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. THERMO FISHER SCIENTIFIC, INC.
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. ILLUMINA, INC.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. BIO-RAD LABORATORIES, INC.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. MOLECULARMD (SUBSIDIARY OF ICON PLC)
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. ARCHERDX, INC.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. ARUP LABORATORIES INC.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. ASURAGEN, INC.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. F. Hoffman-La Roche Ltd.
2. Abbott Laboratories
3. Qiagen N.V.
4. Thermo Fisher Scientific, Inc.
5. Illumina, Inc.
6. Bio-Rad Laboratories, Inc.
7. Molecularmd (Subsidiary of Icon PLC)
8. Archerdx, Inc.
9. Arup Laboratories Inc.
10. Asuragen, Inc. (Suzhou)